The Brain Modulates Insulin Sensitivity in Multiple Tissues

Autor: Parlevliet, E.T., Coomans, C.P., Rensen, P.C.N., Romijn, J.A., Delhanty, P.J.D., VanDerLely, A.J.

Publikováno v: Frontiers of Hormone Research, 42, 50-58

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::8590d4040040bcdeb81cae12636e5f64
https://hdl.handle.net/1887/108050

THE GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST EXENDIN-4 INHIBITS VLDL BIOSYNTHESIS AND SECRETION IN APOE*3-LEIDEN MICE

Autor: Wang, Y., Parlevliet, E.T., Geerling, J.J., Schroder-Van der Elst, J.P., Smit, J.W.A., Havekes, L.M., Romijn, J.A., Pijl, H., Rensen, P.C.N.

Publikováno v: Atherosclerosis. Supplements, 12(1), 2-2

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::2e39ab75d2d9b14c2f54e8d0712ebcfa
https://hdl.handle.net/1887/98408

Gut hormones - Novel tools in the treatment of insulin resistance

Autor: Parlevliet, E.T.

Publikováno v: None

Type 2 diabetes mellitus has now become a global epidemic. The past decade hormones from the gastrointestinal tract have gained much interest as potential new therapeutic drugs in the battle against this disease. Gut peptides play an important role i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::7b25b6ff6d3217659ddd5da58646d20e
https://hdl.handle.net/1887/16080

CNTO736, a novel glucagon-like peptide-1 receptor agonist, ameliorates insulin resistance and inhibits very low-density lipoprotein production in high-fat-fed mice

Autor: Parlevliet, E.T., Schröder-van der Elst, J.P., Corssmit, E.P.M., Picha, K., O'Neil, K., Stojanovic-Susulic, V., Ort, T., Havekes, L.M., Romijn, J.A., Pijl, H.

Publikováno v: Journal of Pharmacology and Experimental Therapeutics, 1, 328, 240-248
The journal of pharmacology and experimental therapeutics, 1, 328, 240-248

CNTO736 is a glucagon-like peptide (GLP) 1 receptor agonist that incorporates a GLP-1 peptide analog linked to the Mimeti-body platform. We evaluate the potential of acute and chronic CNTO736 treatment on insulin sensitivity and very low-density lipo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::84fe69298e6c03f25b285df139344cca
http://resolver.tudelft.nl/uuid:7303251b-345d-4b3c-8ef4-f11ff56f17ff

5 THE GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST EXENDIN-4 INHIBITS VLDL BIOSYNTHESIS AND SECRETION IN APOE*3-LEIDEN MICE

Autor: Wang, Y., Parlevliet, E.T., Geerling, J.J., Schröder-Van der Elst, J.P., Smit, J.W.A., Havekes, L.M., Romijn, J.A., Pijl, H., Rensen, P.C.N.

Publikováno v: In Atherosclerosis (Supplements) (Component) June 2011 12(1):2-2